7147-29-7

Basic information

• Product Name: methyl 13-hydroxytridecanoate
• CAS NO: 7147-29-7
• Molecular Formula: C₁₄H₂₈O₃
• Molecular Weight: 244.3703
• Mol File: 7147-29-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 327.8°C at 760 mmHg
• Flash Point: 123.6°C
• Density: 0.937g/cm³
• Vapor Pressure: 1.48E-05mmHg at 25°C
• Refractive Index: 1.451
• CAS DataBase Reference: methyl 13-hydroxytridecanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 13-hydroxytridecanoate(7147-29-7)
• EPA Substance Registry System: methyl 13-hydroxytridecanoate(7147-29-7)

Safety Data

• Hazardous Substances Data: 7147-29-7(Hazardous Substances Data)

Upstream product

• 7735-38-8 13-hydroxytridecanoic acid 
• 186581-53-3 diazomethane 
• 67-56-1 methanol 
• 88229-67-8 12-(5,5-Dimethyl-4,5-dihydro-oxazol-2-yl)-dodecan-1-ol 
• 3927-59-1 tridecanedioic acid monomethyl ester 
• 33240-34-5 cyclopentylmagnesium bromide 
• 64-17-5 ethanol 
• 1608-77-1 methyl 12-formyldodecanoate 
• 112-86-7 cis-13-docosenoic acid 
• 88229-68-9 Lithium 11-bromoundecoxide 
• 54894-30-3 11-acetoxyundecanoic acid 

Downstream Products

• 4568-88-1 (S)-15,16-dihydroxy-hexadecanoic acid methyl ester 

Relevant articles and documents

Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound

A steroid ester compound of a terminally-fluorinated alkyl fatty acid, a steroid compound having bis(trifluoromethyl)phenyl group, a phosphatidylserine compound having a terminally-fluorinated alkyl group, a glyceride compound having bis(trifluoromethyl phenyl group, or a glyceride compound having a terminally-fluorinated alkyl group. A vascular lesion can be selectively imaged by using a contrast medium comprising a liposome containing said compound or a salt thereof.

Studies on mimicry of naturally occurring annonaceous acetogenins: Non-THF analogues leading to remarkable selective cytotoxicity against human tumor cells

A class of structurally simplified analogues of the naturally occurring annonaceous acetogenins were developed, amongst which some non-THF analogues showed remarkable cytotoxicities against tumor cell lines, as well as good selectivity between human tumor cells and normal cells. The synthetic routes were significantly shortened because of the removal of the chiral centers bearing the THF rings on the natural templates. This simplification also provides access to the parallel synthesis of these mimics by a combinatorial strategy. The remaining stereogenic centers at the positions α to the ethereal links were introduced by the Chiron approach from the easily accessible chiral building blocks 6a and/or 6b, made in turn from L-ascorbic acid or Dmannitol, while the one in the butenolide segment was taken from L-lactate. All four diastereomeric non-THF analogues 2a-2d showed remarkable activity against the HCT-8 cell line, and better differentiation was found when testing against the HT-29 cell line. It was also discovered that both the butenolide and ethylene glycol subunits play essential roles in the cytotoxicities against tumor cell lines, while the 10-substituted hydroxy group and the absolute configuration of methyl group at the butenolide moiety are less important for their activity.

Hydrogenation of carboxylic acids using bimetallic catalysts consisting of Group 8 to 10, and Group 6 or 7 metals

Hydrogenation of carboxylic acids to alcohols was effectively catalyzed by bimetallic systems consisting of Group 8 to 10 late transition-metals, and Group 6 or 7 early transition-metal carbonyls. These catalysts easily converted α,ω-dicarboxylic acid monoesters into ω-hydroxyalkanoic esters in good yields.